LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹133 Cr | ₹101 Cr | ₹101 Cr | ₹90 Cr | ₹88 Cr |
What is the latest Total Liabilities ratio of LACTOSE (INDIA) ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹101 Cr |
| Mar2023 | ₹101 Cr |
| Mar2022 | ₹90 Cr |
| Mar2021 | ₹88 Cr |
How is Total Liabilities of LACTOSE (INDIA) Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹133 Cr | 32.49 | |
| Mar2024 | ₹101 Cr | -0.54 | |
| Mar2023 | ₹101 Cr | 12.27 | |
| Mar2022 | ₹90 Cr | 2.13 | |
| Mar2021 | ₹88 Cr | - | |
Compare Total Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹138.0 Cr | 7% | 4.5% | -6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | 7% |
4.5% |
-6.1% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses